​

Funding Round

Series E - Nuvaira

Series E - Nuvaira

Investment Firm

Overview

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.

Announced Date

Feb 11, 2019

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

U.S. Venture Partners

U.S. Venture Partners

U.S. Venture Partners is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

10

Investor Name
Participant InvestorAdvanced Technology Ventures
Participant InvestorMorgenthaler Ventures
Participant InvestorSplit Rock Partners
Participant InvestorQiming Venture Partners
Participant InvestorU.S. Venture Partners

Round Details and Background

Nuvaira raised $79000000 on 2019-02-11 in Series E

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.

Company Funding History

11

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 20, 2012
Series B - Nuvaira
4-10.6M
Sep 29, 2010
Series A - Nuvaira
2-3.0M
Feb 08, 2013
Series C - Nuvaira
4-10.0M
Apr 03, 2014
Series D - Nuvaira
7-42.0M

Recent Activity

There is no recent news or activity for this profile.